These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15231742)

  • 1. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.
    Kahlem P; Sultan M; Herwig R; Steinfath M; Balzereit D; Eppens B; Saran NG; Pletcher MT; South ST; Stetten G; Lehrach H; Reeves RH; Yaspo ML
    Genome Res; 2004 Jul; 14(7):1258-67. PubMed ID: 15231742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
    Lyle R; Gehrig C; Neergaard-Henrichsen C; Deutsch S; Antonarakis SE
    Genome Res; 2004 Jul; 14(7):1268-74. PubMed ID: 15231743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
    Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of trisomic proteins in Down syndrome model systems.
    Spellman C; Ahmed MM; Dubach D; Gardiner KJ
    Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of Down syndrome: gene content and consequences.
    Gupta M; Dhanasekaran AR; Gardiner KJ
    Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome.
    Akeson EC; Lambert JP; Narayanswami S; Gardiner K; Bechtel LJ; Davisson MT
    Cytogenet Cell Genet; 2001; 93(3-4):270-6. PubMed ID: 11528125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-dosage effects in Down syndrome and trisomic mouse models.
    Gardiner K
    Genome Biol; 2004; 5(10):244. PubMed ID: 15461808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal loss of Ts65Dn Down syndrome mice.
    Roper RJ; St John HK; Philip J; Lawler A; Reeves RH
    Genetics; 2006 Jan; 172(1):437-43. PubMed ID: 16172497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
    Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
    Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
    Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
    Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
    BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.
    Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH
    Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression variation in Down's syndrome mice allows prioritization of candidate genes.
    Sultan M; Piccini I; Balzereit D; Herwig R; Saran NG; Lehrach H; Reeves RH; Yaspo ML
    Genome Biol; 2007; 8(5):R91. PubMed ID: 17531092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.